Ulcerative colitis and rheumatoid a1thritis research hub

A Phase I study to evaluate the pharmacokinetics, safety, and tolerability of multiple oral doses of obefazimod in patients with mild and moderate hepatic impairment, compared to matched control groups.

This study is looking at a new medicine called obefazimod for conditions like ulcerative colitis and rheumatoid arthritis. It's an early-stage study to understand how the medicine works in people with liver problems compared to those with healthy livers, to make sure it's safe.